Back

Defibrillation testing at implant of subcutaneous implantable cardioverter defibrillator: weighting propensity score analysis and results from nationwide HONEST cohort

31 March 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Device therapy (2) Cardioversion and Defibrillation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Fawzi kerkouri

University Hospital of Brest, Brest (France)

6 More presentations in this session

Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator in pediatric and young adults: an analysis from the European SIDECAR Registry
Doctor M. Silvetti (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Bidirectional interaction between implantable cardioverter-defibrillator therapy and mental disorders: nationwide cohort study
Doctor J. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Deprivation and device therapy: understanding the impact of socioeconomic status on ICD therapy outcomes
Mr C. Monkhouse (London, GB)
Abstract Slides Video
Presentation thumbnail
Predictors of syncope recurrence in reflex syncope patients with dual-chamber pacemakers with anti-reflex functionality
Doctor T. Vo (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
Implantable cardioverter defibrillator resistant mortality in ischemic and dilated cardiomyopathy across therapeutic eras: a single, tertiary center experience
Doctor M. Blondeel (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Device therapy (2)

The Event

Event poster

EHRA 2025

31 March 2025 12:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources